Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Dichlofenal
2. Diclofenac
3. Diclofenac Sodium
4. Diclofenac, Sodium
5. Diclonate P
6. Diclophenac
7. Dicrofenac
8. Feloran
9. Gp 45,840
10. Gp-45,840
11. Gp45,840
12. Novapirina
13. Orthofen
14. Orthophen
15. Ortofen
16. Sodium Diclofenac
17. Sr 38
18. Sr-38
19. Sr38
20. Voltaren
21. Voltarol
1. 15307-81-0
2. Cataflam
3. Cgp 45840b
4. Voltfast
5. Cambia
6. Zipsor
7. Diclofenac Potassium [usan:usp]
8. Potassium Diclofenac
9. Potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
10. Diclofenac (potassium)
11. Cgp-45840b
12. Diclofenac Potassium Salt
13. L4d5ua6cb4
14. Chebi:4508
15. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Monopotassium Salt
16. Potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
17. Cataflam; Diclofenac Potassium; K-fenak; Potassium Diclofenac; Prosorb
18. Diclofenac Potassium [usan]
19. Unii-l4d5ua6cb4
20. Cataflam (tn)
21. Potassium (o-(2,6-dichloroanilino)phenyl)acetate
22. Cambia (tn)
23. Zipsor (tn)
24. Diclofenac Potassium (usp)
25. Schembl40784
26. Chembl1200804
27. Dtxsid30165212
28. Hms3656d18
29. Diclofenac Potassium [vandf]
30. Diclofenac Potassium [mart.]
31. S3062
32. Diclofenac Potassium [usp-rs]
33. Diclofenac Potassium [who-dd]
34. Akos015889752
35. Akos015994733
36. Diclofenac Potassium Salt [mi]
37. Ccg-267848
38. Ks-5037
39. Ac-18735
40. Diclofenac Potassium [orange Book]
41. Hy-15038
42. Diclofenac Potassium [ep Monograph]
43. Db-043176
44. Diclofenac Potassium [usp Monograph]
45. Cs-0003712
46. Ft-0603076
47. Sw196404-4
48. D00903
49. Q27106401
50. Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
51. Potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
52. Potassium (o-((2,6-dichlorophenyl)amino)phenyl)acetate
53. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Monopotassium Salt
Molecular Weight | 334.2 g/mol |
---|---|
Molecular Formula | C14H10Cl2KNO2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 4 |
Exact Mass | 332.9725654 g/mol |
Monoisotopic Mass | 332.9725654 g/mol |
Topological Polar Surface Area | 52.2 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 310 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 8 | |
---|---|
Drug Name | Cambia |
Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
Active Ingredient | Diclofenac potassium |
Dosage Form | For solution |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Depomed |
2 of 8 | |
---|---|
Drug Name | Cataflam |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Novartis |
3 of 8 | |
---|---|
Drug Name | Diclofenac potassium |
Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva; Apotex; Sandoz; Mylan |
4 of 8 | |
---|---|
Drug Name | Zipsor |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Capsule |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Depomed |
5 of 8 | |
---|---|
Drug Name | Cambia |
Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
Active Ingredient | Diclofenac potassium |
Dosage Form | For solution |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Depomed |
6 of 8 | |
---|---|
Drug Name | Cataflam |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Novartis |
7 of 8 | |
---|---|
Drug Name | Diclofenac potassium |
Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Tablet |
Route | Oral |
Strength | 50mg |
Market Status | Prescription |
Company | Teva; Apotex; Sandoz; Mylan |
8 of 8 | |
---|---|
Drug Name | Zipsor |
PubMed Health | Diclofenac |
Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
Active Ingredient | Diclofenac potassium |
Dosage Form | Capsule |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Depomed |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
27
PharmaCompass offers a list of Diclofenac Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diclofenac Potassium manufacturer or Diclofenac Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclofenac Potassium manufacturer or Diclofenac Potassium supplier.
PharmaCompass also assists you with knowing the Diclofenac Potassium API Price utilized in the formulation of products. Diclofenac Potassium API Price is not always fixed or binding as the Diclofenac Potassium Price is obtained through a variety of data sources. The Diclofenac Potassium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zipsor manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zipsor, including repackagers and relabelers. The FDA regulates Zipsor manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zipsor API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zipsor manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zipsor supplier is an individual or a company that provides Zipsor active pharmaceutical ingredient (API) or Zipsor finished formulations upon request. The Zipsor suppliers may include Zipsor API manufacturers, exporters, distributors and traders.
click here to find a list of Zipsor suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zipsor DMF (Drug Master File) is a document detailing the whole manufacturing process of Zipsor active pharmaceutical ingredient (API) in detail. Different forms of Zipsor DMFs exist exist since differing nations have different regulations, such as Zipsor USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zipsor DMF submitted to regulatory agencies in the US is known as a USDMF. Zipsor USDMF includes data on Zipsor's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zipsor USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zipsor suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zipsor Drug Master File in Korea (Zipsor KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zipsor. The MFDS reviews the Zipsor KDMF as part of the drug registration process and uses the information provided in the Zipsor KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zipsor KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zipsor API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zipsor suppliers with KDMF on PharmaCompass.
A Zipsor CEP of the European Pharmacopoeia monograph is often referred to as a Zipsor Certificate of Suitability (COS). The purpose of a Zipsor CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zipsor EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zipsor to their clients by showing that a Zipsor CEP has been issued for it. The manufacturer submits a Zipsor CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zipsor CEP holder for the record. Additionally, the data presented in the Zipsor CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zipsor DMF.
A Zipsor CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zipsor CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zipsor suppliers with CEP (COS) on PharmaCompass.
A Zipsor written confirmation (Zipsor WC) is an official document issued by a regulatory agency to a Zipsor manufacturer, verifying that the manufacturing facility of a Zipsor active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Zipsor APIs or Zipsor finished pharmaceutical products to another nation, regulatory agencies frequently require a Zipsor WC (written confirmation) as part of the regulatory process.
click here to find a list of Zipsor suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Zipsor as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Zipsor API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Zipsor as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Zipsor and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Zipsor NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Zipsor suppliers with NDC on PharmaCompass.
Zipsor Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zipsor GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zipsor GMP manufacturer or Zipsor GMP API supplier for your needs.
A Zipsor CoA (Certificate of Analysis) is a formal document that attests to Zipsor's compliance with Zipsor specifications and serves as a tool for batch-level quality control.
Zipsor CoA mostly includes findings from lab analyses of a specific batch. For each Zipsor CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zipsor may be tested according to a variety of international standards, such as European Pharmacopoeia (Zipsor EP), Zipsor JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zipsor USP).